News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
801,651 Results
Type
Article (55920)
Company Profile (319)
Press Release (745393)
Multimedia
Podcasts (141)
Webinars (26)
Section
Business (222089)
Career Advice (2973)
Deals (38008)
Drug Delivery (158)
Drug Development (87431)
Employer Resources (186)
FDA (17638)
Job Trends (16166)
News (376031)
Policy (36376)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2963)
Academic (1)
Accelerated approval (50)
Adcomms (38)
Allergies (184)
Alliances (53694)
ALS (225)
Alzheimer's disease (1922)
Antibody-drug conjugate (ADC) (500)
Approvals (17966)
Artificial intelligence (739)
Autoimmune disease (316)
Automation (57)
Bankruptcy (394)
Best Places to Work (12235)
BIOSECURE Act (21)
Biosimilars (237)
Biotechnology (204)
Bladder cancer (207)
Brain cancer (80)
Breast cancer (796)
Cancer (6177)
Cardiovascular disease (518)
Career advice (2532)
Career pathing (49)
CAR-T (355)
CDC (69)
Celiac Disease (3)
Cell therapy (977)
Cervical cancer (48)
Clinical research (75492)
Collaboration (2209)
Company closure (6)
Compensation (1435)
Complete response letters (97)
COVID-19 (2970)
CRISPR (117)
C-suite (1221)
Cystic fibrosis (157)
Data (8203)
Decentralized trials (3)
Denatured (40)
Depression (184)
Dermatology (92)
Diabetes (621)
Diagnostics (7381)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (353)
Drug pricing (232)
Drug shortages (35)
Duchenne muscular dystrophy (305)
Earnings (98310)
Editorial (76)
Employer branding (24)
Employer resources (164)
Events (130891)
Executive appointments (1163)
FDA (21498)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1826)
Gene editing (254)
Generative AI (65)
Gene therapy (794)
GLP-1 (1195)
Government (5297)
Grass and pollen (8)
Guidances (411)
Healthcare (20482)
HIV (88)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (101)
Immunology and inflammation (334)
Immuno-oncology (104)
Indications (197)
Infectious disease (3340)
Inflammatory bowel disease (233)
Inflation Reduction Act (15)
Influenza (142)
Intellectual property (300)
Interviews (573)
IPO (17385)
IRA (57)
Job creations (4246)
Job search strategy (2054)
JPM (68)
Kidney cancer (21)
Labor market (103)
Layoffs (640)
Leadership (49)
Legal (9061)
Liver cancer (108)
Longevity (34)
Lung cancer (817)
Lymphoma (440)
Machine learning (62)
Management (63)
Manufacturing (1112)
MASH (210)
Medical device (14777)
Medtech (14912)
Mergers & acquisitions (21878)
Metabolic disorders (1645)
mRNA (239)
Multiple sclerosis (198)
NASH (24)
Neurodegenerative disease (465)
Neuropsychiatric disorders (121)
Neuroscience (3558)
Neurotech (1)
NextGen: Class of 2026 (7170)
Non-profit (4964)
Now hiring (78)
Obesity (783)
Opinion (352)
Ovarian cancer (233)
Pain (275)
Pancreatic cancer (321)
Parkinson's disease (391)
Partnered (33)
Patents (621)
Patient recruitment (704)
Peanut (67)
People (65341)
Pharmaceutical (66)
Pharmacy benefit managers (35)
Phase 1 (23440)
Phase 2 (33073)
Phase 3 (24749)
Pipeline (9125)
Policy (371)
Postmarket research (2997)
Preclinical (10097)
Press Release (71)
Prostate cancer (321)
Psychedelics (67)
Radiopharmaceuticals (347)
Rare diseases (1188)
Real estate (6621)
Recruiting (77)
Regulatory (27772)
Reports (57)
Research institute (2663)
Resumes & cover letters (466)
Rett syndrome (40)
RNA editing (25)
RSV (94)
Schizophrenia (193)
Series A (308)
Series B (225)
Service/supplier (13)
Sickle cell disease (121)
Special edition (30)
Spinal muscular atrophy (181)
Sponsored (51)
Startups (3979)
State (2)
Stomach cancer (21)
Supply chain (134)
Tariffs (98)
The Weekly (98)
Vaccines (1221)
Venture capital (122)
Weight loss (526)
Women's health (131)
Worklife (23)
Date
Today (47)
Last 7 days (603)
Last 30 days (3420)
Last 365 days (31590)
2026 (13754)
2025 (31705)
2024 (36861)
2023 (41863)
2022 (53151)
2021 (57863)
2020 (56717)
2019 (49916)
2018 (37843)
2017 (34732)
2016 (34905)
2015 (41068)
2014 (35392)
2013 (30805)
2012 (32825)
2011 (33455)
2010 (31935)
Location
Africa (965)
Alabama (96)
Alaska (7)
Arizona (371)
Arkansas (16)
Asia (45054)
Australia (8108)
California (13743)
Canada (3866)
China (1442)
Colorado (586)
Connecticut (602)
Delaware (425)
Europe (101095)
Florida (2036)
Georgia (446)
Hawaii (3)
Idaho (66)
Illinois (1119)
India (95)
Indiana (620)
Iowa (24)
Japan (556)
Kansas (137)
Kentucky (52)
Louisiana (45)
Maine (89)
Maryland (1648)
Massachusetts (9940)
Michigan (397)
Minnesota (759)
Mississippi (7)
Missouri (158)
Montana (37)
Nebraska (29)
Nevada (147)
New Hampshire (89)
New Jersey (3630)
New Mexico (32)
New York (3595)
North Carolina (1826)
North Dakota (11)
Northern California (6882)
Ohio (415)
Oklahoma (24)
Oregon (45)
Pennsylvania (2742)
Puerto Rico (30)
Rhode Island (52)
South America (1340)
South Carolina (87)
South Dakota (2)
Southern California (5417)
Tennessee (219)
Texas (2199)
United States (48833)
Utah (412)
Vermont (1)
Virginia (337)
Washington D.C. (86)
Washington State (1109)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
801,651 Results for "integer holdings corporation formerly known as greatbatch inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Britannia Life Sciences Provides Corporate Update
Corporate Treasury Positioned with Cash and Liquid Equity Holdings to Seed, Incubate and Accelerate New and Existing Operations
May 21, 2026
·
4 min read
Press Releases
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio
May 7, 2026
·
4 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Business
Integer Holdings Corporation Reports First Quarter 2024 Results
Integer Holdings Corporation announced results for the three months ended March 29, 2024.
April 25, 2024
·
26 min read
Press Releases
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
May 8, 2026
·
18 min read
Press Releases
Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results
May 8, 2026
·
10 min read
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.
March 12, 2026
·
1 min read
·
Annalee Armstrong
Deals
Integer Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies
Integer Holdings Corporation announced fourth quarter 2023 preliminary unaudited sales are expected to be in the range of $411 million to $413 million, an increase of 10% to 11% compared to fourth quarter 2022.
January 10, 2024
·
9 min read
Lone Star Bio
Integer to Present at 2024 Bank of America Securities Healthcare Conference on May 14
Integer Holdings Corporation today announced participation in the 2024 Bank of America Securities Healthcare Conference, to be held May 14 – 16, 2024, in Las Vegas.
May 1, 2024
·
1 min read
Business
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2023
Integer Holdings Corporation, a leading medical device outsource manufacturer, announced results for the three and twelve months ended December 31, 2023.
February 15, 2024
·
32 min read
1 of 80,166
Next
